Exploring the clinical pharmacist's role in improving home care for patients with diabetes

Home Care Provider

Volumn 5, Issue 5, 2000, Pages 185-192

  Setter, Stephen M ^a,b   Corbett, Cynthia F ^c   Cook, Dave ^b   Johnson, Steven B ^d  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Visiting Nurses Association   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL PHARMACOLOGY; DIABETES MELLITUS; FEMALE; HOME CARE; HUMAN; MALE; MIDDLE AGED; NURSING; PATIENT CARE PLANNING; UNITED STATES;

ADULT; AGED; DIABETES MELLITUS; FEMALE; HOME CARE SERVICES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT CARE PLANNING; PHARMACOLOGY, CLINICAL; WASHINGTON;

EID: 0034308968     PISSN: 1084628X     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhc.2000.110686     Document Type: Article

References (13)

1. American Diabetes Association. Diabetes 1996 vital statistics. Alexandria (VA): The Association; 1996. p. 13.
2. Polonsky KS, Sturis J, Bell GI. Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996;334:777-83.
3. Nestler JE. Syndrome X. Semin Reprod Endocrinol 1997;15:111-22.
4. Currie CJ, Morgan, CL, Peters JR. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care 1998;21:42-8.
5. Selby JV, Ray, GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997;20:1396-402.
6. Helberg J. Use of home care nursing resources by the elderly. Public Health Nursing 1994;11:104-12.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
8. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
9. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994;154:2169-78.
10. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
11. Cowper PA, Weinberger M, Hanlon JT, Landsman PB, Samsa GP, et al. The costeffectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy 1998;18:327-32.
12. Corbett CE Research-based practice implications for patients with diabetes - part 1: diabetes knowledge. Home Healthcare Nurse 1999;17:511-8.
13. Der Hsia E, Rubenstein LZ, Choy GS. The benefits of in-home pharmacy evaluation for older persons. J Am Geriatr Soc 1997;45:211-4.